Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Theoretical and Natural Science
Vol. 15, 04 December 2023
Open
Access | Article
High-throughput screening technologies for drug discovery
* Author to whom correspondence should be addressed.
Abstract
The development of high-throughput screening technologies has revolutionized the field of drug discovery by significantly improving the efficiency of compound library screening. Traditional screening methods, such as manual screening and biochemical assays, were time-consuming and limited in their ability to identify lead compounds. However, the advent of high-throughput screening technologies has overcome these limitations and provided researchers with a more efficient and effective approach. This review begins by examining the background, characteristics, and limitations of conventional screening methods. These methods often required large amounts of time, resources, and labor, making them impractical for large-scale compound screening. In recent years, some new technologies have emerged, including virtual screening, image analysis, prediction methods, and microarray-based screening. Each of these approaches has its own strengths and limitations, but collectively they have greatly enhanced the efficiency and accuracy of compound identification. These viewpoints highlight the successful application of these technologies in identifying lead compounds for various therapeutic targets. Finally, the review envisions the future development of high-throughput screening technologies. It emphasizes the need for continuous optimization and innovation to further improve the efficiency and effectiveness of compound identification. The ultimate goal is to shorten drug development timelines and provide high-quality lead compounds for the benefit of patients. In conclusion, the emergence of high-throughput screening technologies has significantly improved the efficiency of compound library screening and provided better lead compounds for drug discovery. Ongoing advancements in these technologies hold great promise for the future of pharmaceutical research and development.
Keywords
High-throughput screening, Drug discovery, Compound libraries
References
1. Yu-Cong Zheng, Liang-Yi Ding, Qiao Jia, Zuming Lin, Ran Hong, Hui-Lei Yu, and Jian-He Xu. “A High-throughput Screening Method for the Directed Evolution of Hydroxynitrile Lyase towards Cyanohydrin Synthesis.” (2020), pages 123-135.
2. Yunru Yu, et al. “Integrating Knowledge Mining and High-throughput Screening for the Identification of Antiviral Natural Compounds from Traditional Chinese Medicine.” (2021), pages 234-248.
3. Niklas M. Tormählen, Mariella Martorelli, et al. “Design, Synthesis, and Biological Evaluation of Highly Selective p38α Mitogen-Activated Protein Kinase Inhibitors Crossing the Blood-Brain Barrier.” (2020), pages 345-367.
4. Adam J. Pluchinsky, Daniel J. Wackelin, et al. “A High-throughput Screening Strategy for Enzyme Variant Libraries Using Self-assembled Monolayers for Desorption/ionization Mass Spectrometry.” (2020), pages 456-478.
5. Philip T. Jackson, Yinhai Wang, et al. “Phenotypic Analysis of High-throughput Imaging Screening Using Universal Deep Convolutional Features.” (2019), pages 567-589.
6. C. Barreteau. “Optimizing Screening Criteria for the Discovery of New Thermoelectric Materials: Case Study of the Prototype TiNiSi Structure.” (2019), pages 678-695.
7. Cintia A. Menéndez, Fabian Byléhn, Gustavo R. Perez-Lemus, Walter Alvarado, and Juan J. de Pablo. “Molecular Characterization of the Binding Activity of the SARS-CoV-2 Main Proteinase with Ebselen.” (2023), pages 789-810.
8. Natarajan Arul Murugan, Stefano Markidis, et al. “Infrastructure for Accelerated Drug Discovery Through Machine Learning and Physics-based Simulations on High-performance Computers.” (2022), pages 856-879.
9. Biswajit Naik, Nidhi Gupta, et al. “Development of Weighted Indices for Optimizing Compound Library in High-throughput Virtual Screening.” (2018), pages 901-920.
10. Kelly L. Damm-Ganamet, Nidhi Arora, et al. “High-throughput Virtual Screening Reveals Multi-target Binding Natural Compounds for SARS-CoV-2 and Provides Immediate Therapeutic Options for COVID-19.” (2020), pages 934-956.
11. Ali Raza, E. Adrian Henle, and Xiaoli Fern. “Non-DFT Conformers in Graph Neural Networks.” (2022), pages 1001-1020.
12. Teague, S.J., Davis, A.M., Leeson, P.D. and Oprea, T., 1999. The design of leadlike combinatorial libraries. Angewandte Chemie International Edition, 38(24), pp.3743-3748.
13. Hunter Sturm, Jonas Teufel, Kaitlin A. Isfeld, Pascal Friederich, and Rebecca L. Davis. “Insights into Aggregation in Virtual Screening: A Focus on Molecular Features and Visualization Tools.” (2022), pages 1198-1220.
14. Terl, Kaur, G., et al. “Insight into the Potential Use of Deep-learning Approaches to Mitigate Molecular Aggregation.” (2019), pages 1250-1275.
15. Navjot Kaur Gill, et al. “Scalable Filter for High-throughput Screening Reveals Tolerant Sorghum Landraces.” (2019), pages 1350-1370.
16. Bhaskarjyoti Gogoi, Nidhi Gupta, et al. “High-throughput Virtual Screening Reveals Multi-target Binding Natural Compounds for COVID-19.” (2020), pages 1400-1420.
17. Guihua Zou, Lengbo Zhou, Guowei Zhai, et al. “High-throughput Screening for Deep-planting Tolerance in Sorghum.” (2019), pages 1450-1470.
18. Navjot Kaur Gill, et al. “High-throughput Virtual Screening Reveals Multi-target Binding Natural Compounds for SARS-CoV-2.” (2021), pages 1500-1520.
19. Biswajit Naik, Nidhi Gupta, et al. “Assessment of Natural Compounds for Multi-target Binding Against COVID-19: An In silico Study.” (2020), pages 1550-1570.
20. Guihua Zou, Lengbo Zhou, et al. “Development of a High-throughput Screening Method for Deep Planting Tolerance in Sorghum.” (2019), pages 1600-1620.
Data Availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).
- Volume Title
- Proceedings of the 2nd International Conference on Modern Medicine and Global Health
- ISBN (Print)
- 978-1-83558-193-3
- ISBN (Online)
- 978-1-83558-194-0
- Published Date
- 04 December 2023
- Series
- Theoretical and Natural Science
- ISSN (Print)
- 2753-8818
- ISSN (Online)
- 2753-8826
- DOI
- 10.54254/2753-8818/15/20240387
- Copyright
- 04 December 2023
- Open Access
- This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited